239 related articles for article (PubMed ID: 24771250)
1. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Samuel N; Remke M; Rutka JT; Raught B; Malkin D
J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
Mikolajewicz N; Yee PP; Bhanja D; Trifoi M; Miller AM; Metellus P; Bagley SJ; Balaj L; de Macedo Filho LJM; Zacharia BE; Aregawi D; Glantz M; Weller M; Ahluwalia MS; Kislinger T; Mansouri A
J Clin Oncol; 2024 Jun; 42(16):1961-1974. PubMed ID: 38608213
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C
Neoplasia; 2023 Jan; 35():100852. PubMed ID: 36516487
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD).
Bruschi M; Petretto A; Cama A; Pavanello M; Bartolucci M; Morana G; Ramenghi LA; Garré ML; Ghiggeri GM; Panfoli I; Candiano G
Sci Rep; 2021 Jan; 11(1):1818. PubMed ID: 33469081
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
9. Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study.
Kajana X; Spinelli S; Garbarino A; Balagura G; Bartolucci M; Petretto A; Pavanello M; Candiano G; Panfoli I; Bruschi M
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136601
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors.
Desiderio C; D'Angelo L; Rossetti DV; Iavarone F; Giardina B; Castagnola M; Massimi L; Tamburrini G; Di Rocco C
Proteomics; 2012 Jul; 12(13):2158-66. PubMed ID: 22623401
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Wesenhagen KEJ; Teunissen CE; Visser PJ; Tijms BM
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):86-98. PubMed ID: 31694431
[TBL] [Abstract][Full Text] [Related]
12. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
13. The proteomics of pediatric brain tumors.
Anagnostopoulos AK; Tsangaris GT
Expert Rev Proteomics; 2014 Oct; 11(5):641-8. PubMed ID: 25059388
[TBL] [Abstract][Full Text] [Related]
14. Neuroproteomic Profiling of Cerebrospinal Fluid (CSF) by Multiplexed Affinity Arrays.
Häggmark-Månberg A; Nilsson P; Schwenk JM
Methods Mol Biol; 2017; 1598():247-254. PubMed ID: 28508365
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
[TBL] [Abstract][Full Text] [Related]
17. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery.
Núñez Galindo A; Kussmann M; Dayon L
Anal Chem; 2015 Nov; 87(21):10755-61. PubMed ID: 26452177
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.
Zheng PP; Luider TM; Pieters R; Avezaat CJ; van den Bent MJ; Sillevis Smitt PA; Kros JM
J Neuropathol Exp Neurol; 2003 Aug; 62(8):855-62. PubMed ID: 14503641
[TBL] [Abstract][Full Text] [Related]
20. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
